Literature DB >> 27177721

Nanoparticles Based on Linear and Star-Shaped Poly(Ethylene Glycol)-Poly(ε-Caprolactone) Copolymers for the Delivery of Antitubulin Drug.

Karim S Shalaby1, Mahmoud E Soliman1, Giulia Bonacucina2, Marco Cespi2, Giovanni F Palmieri2, Omaima A Sammour1, Abdelhameed A El Shamy1, Lisbeth Illum3, Luca Casettari4.   

Abstract

PURPOSE: Biodegradable polymeric nanoparticles of different architectures based on polyethylene glycol-co-poly(ε-caprolactone) block copolymers have been loaded with noscapine (NOS) to study their effect on its anticancer activity. It was intended to use solubility of NOS in an acidic environment and ability of the nanoparticles to passively target drugs into cancer tissue to modify the NOS pharmacokinetic properties and reduce the requirement for frequent injections.
METHODS: Linear and star-shaped copolymers were synthetized and used to formulate NOS loaded nanoparticles. Cytotoxicity was performed using a sulforhodamine B method on MCF-7 cells, while biocompatibility was determined on rats followed by hematological and histopathological investigations.
RESULTS: Formulae with the smallest particle sizes and adequate entrapment efficiency revealed that NOS loaded nanoparticles showed higher extent of release at pH 4.5. Colloidal stability suggested that nanoparticles would be stable in blood when injected into the systemic circulation. Loaded nanoparticles had IC50 values lower than free drug. Hematological and histopathological studies showed no difference between treated and control groups. Pharmacokinetic analysis revealed that formulation P1 had a prolonged half-life and better bioavailability compared to drug solution.
CONCLUSIONS: Formulation of NOS into biodegradable polymeric nanoparticles has increased its efficacy and residence on cancer cells while passively avoiding normal body tissues. Graphical Abstract ᅟ.

Entities:  

Keywords:  noscapine; pH dependent release; passive targeting; polyethylene glycol-co-poly(ε-caprolactone) (PEG-co-PCL); polymeric nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27177721     DOI: 10.1007/s11095-016-1939-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  55 in total

Review 1.  Polymeric micelles drug delivery system in oncology.

Authors:  Jian Gong; Meiwan Chen; Ying Zheng; Shengpeng Wang; Yitao Wang
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

2.  Facile synthesis of responsive nanoparticles with reversible, tunable and rapid thermal transitions from biocompatible constituents.

Authors:  Samer R Abulateefeh; Aram O Saeed; Jonathan W Aylott; Weng C Chan; Martin C Garnett; Brian R Saunders; Cameron Alexander
Journal:  Chem Commun (Camb)       Date:  2009-08-24       Impact factor: 6.222

Review 3.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

4.  NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin.

Authors:  Amane Takahashi; Yoshiyuki Yamamoto; Masahiro Yasunaga; Yoshikatsu Koga; Jun-ichiro Kuroda; Misato Takigahira; Mitsunori Harada; Hiroyuki Saito; Tatsuyuki Hayashi; Yasuki Kato; Taira Kinoshita; Nobuhiro Ohkohchi; Ichinosuke Hyodo; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2013-04-19       Impact factor: 6.716

5.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

6.  Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions.

Authors:  Jianxun Ding; Chunsheng Xiao; Yuce Li; Yilong Cheng; Nannan Wang; Chaoliang He; Xiuli Zhuang; Xiaojuan Zhu; Xuesi Chen
Journal:  J Control Release       Date:  2012-12-16       Impact factor: 9.776

7.  Pharmacokinetic properties of noscapine.

Authors:  B Dahlström; T Mellstrand; C G Löfdahl; M Johansson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy.

Authors:  Jitender Madan; Sushma R Gundala; Yoganjaneyulu Kasetti; Prasad V Bharatam; Ritu Aneja; Anju Katyal; Upendra K Jain
Journal:  Anticancer Drugs       Date:  2014-07       Impact factor: 2.248

9.  Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis.

Authors:  Safaa Sebak; Maryam Mirzaei; Meenakshi Malhotra; Arun Kulamarva; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2010-09-20

Review 10.  Recent advances in PEG-PLA block copolymer nanoparticles.

Authors:  Ren Zhong Xiao; Zhao Wu Zeng; Guang Lin Zhou; Jun Jie Wang; Fan Zhu Li; An Ming Wang
Journal:  Int J Nanomedicine       Date:  2010-11-26
View more
  1 in total

1.  Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.

Authors:  Omar Abdifetah; Kesara Na-Bangchang
Journal:  Int J Nanomedicine       Date:  2019-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.